Drugs Containing Excipient (Inactive Ingredient) LACTIC ACID

Branded drugs containing LACTIC ACID excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Pharmacia & Upjohn Company LLC	CAMPTOSAR	irinotecan hydrochloride	0009-7529	LACTIC ACID
Allergan Inc	CONDYLOX	podofilox	0023-6118	LACTIC ACID
Novartis Pharmaceuticals Corporation	SANDOSTATIN	octreotide acetate	0078-0180	LACTIC ACID
Bausch Health US LLC	MESTINON	pyridostigmine bromide	0187-3012	LACTIC ACID
Bayer HealthCare LLC	ALEVE	naproxen sodium	0280-6080	LACTIC ACID
Bayer HealthCare LLC	ALEVE	naproxen sodium	0280-6091	LACTIC ACID

Generic drugs containing LACTIC ACID excipient

Company	Ingredient	NDC	Excipient
Pharmacia & Upjohn Company LLC	irinotecan hydrochloride	0009-7529	LACTIC ACID
Allergan Inc	podofilox	0023-6118	LACTIC ACID
Novartis Pharmaceuticals Corporation	octreotide acetate	0078-0180	LACTIC ACID
L Perrigo Company	minoxidil	0113-0294	LACTIC ACID
L Perrigo Company	minoxidil	0113-1129	LACTIC ACID
L Perrigo Company	minoxidil	0113-5129	LACTIC ACID

Market Dynamics and Financial Trajectory for Lactic Acid in the Pharmaceutical Excipient Sector

Last updated: February 20, 2026

What are the primary drivers influencing the demand for lactic acid in pharmaceuticals?

The demand for lactic acid in pharmaceuticals stems from its role as an excipient and functional ingredient in drug formulations. Key drivers include:

• Increase in pharmaceutical formulations integrating biodegradable, natural excipients
• Growth in the biopharmaceutical sector, which prefers bio-based, non-toxic excipients
• Rising demand for oral and topical drugs that utilize lactic acid for pH regulation, preservative functions, and bioadhesive properties
• Stringent regulatory standards favoring safe, well-characterized excipients derived from natural sources

Market reports highlight that the pharmaceutical industry's push toward sustainable, non-synthetic excipients amplifies lactic acid's relevance. The global pharmaceutical excipient market size is projected to reach USD 7.7 billion by 2025, with lactic acid's share growing concurrently [1].

How has the supply chain for lactic acid evolved?

Lactic acid production primarily uses fermentation of carbohydrate substrates, with two main types:

• Food-grade lactic acid from sugar sources
• pharmaceutical-grade lactic acid, which requires high purity levels

Recent innovations include:

• Adoption of bio-based fermentation methods employing genetically engineered bacteria to enhance yield and reduce production costs
• Increased capacity from Asia-Pacific region, notably China and India, which dominate global production volumes
• Implementation of sustainable practices reducing dependency on petrochemical derivatives

These advancements have led to increased supply reliability and lowered costs, affecting market competitiveness.

What are the key market segments for lactic acid as a pharmaceutical excipient?

Lactic acid's primary applications in pharma include:

• pH adjuster in injectable, oral, and topical formulations
• Preservative agent in various drug forms
• Bioadhesive and gelling agent in controlled-release systems

Segment growth patterns:

Segment	2022 Revenue (USD million)	CAGR (2022-2027)
pH Adjusters	250	6.2%
Preservatives	150	5.8%
Bioadhesives & Gels	100	7.4%

The pH adjuster segment remains dominant, comprising approximately 55% of lactic acid use, with bioadhesives seeing a notable CAGR of 7.4% due to the growth of controlled-release drug systems.

What are the regulatory considerations affecting the market?

Lactic acid in pharma must adhere to:

• United States Pharmacopeia (USP) standards
• European Pharmacopoeia standards
• International Conference on Harmonisation (ICH) guidelines

Approval timelines for new formulations containing lactic acid generally proceed efficiently if they meet purity and safety standards, supporting market expansion. Increasing regulatory emphasis on non-toxic, natural excipients favors lactic acid's adoption.

What is the financial outlook for lactic acid producers?

The forecast indicates steady growth:

• The global lactic acid market is expected to grow at a CAGR of 6.1% from 2022 to 2027 [2].
• Pharmaceutical sector's share is anticipated to grow from 15% in 2022 to 22% in 2027, driven by escalating demand for safe excipients.

Major manufacturers like Corbion, Galactic, and CJ CheilJedang expanded capacities recently, indicating confidence in future demand. Capital investments include:

• Corbion's USD 500 million expansion of fermentation capacity (completed 2022)
• Galactic deploying new bio-reactors for higher purity production

Profit margins for specialty-grade lactic acid in pharma are typically around 20-25%, higher than non-pharmaceutical grades, reflecting premium pricing enabled by regulatory compliance and superior purity.

How do competitive and pricing dynamics influence financial trajectories?

Price points:

Product Grade	2022 Avg. Price (USD/kg)	2027 Projection (USD/kg)
Food-grade	0.9	0.8
Industrial-grade	1.2	1.1
Pharmaceutical-grade	2.5	2.3

Premium prices for pharma-grade lactic acid position players for higher margins. Market competition is intensifying as new entrants enter the bio-fermentation market, but high entry barriers and strict quality standards maintain supplier dominance.

What are the risks and challenges in the market?

• Fluctuations in feedstock prices (sugar, corn)
• Stringent regulatory standards increasing compliance costs
• Capacity oversupply in the food-grade segment pressuring prices
• Technological hurdles to meet pharmaceutical purity levels at scale

Key Takeaways

• Usage of lactic acid in pharma is growing due to its natural, biodegradable characteristics, and regulatory favorability.
• Production capacity expansion, mainly in Asia, sustains supply growth, but price competition persists.
• The market's growth is driven by demand for pH adjustments, preservatives, and bioadhesive applications.
• Capital investments from leading producers bolster capacity and profitability.
• Regulatory compliance and feedstock availability are critical for maintaining margins and growth.

FAQs

Q1: What factors could most affect the price of pharmaceutical-grade lactic acid?
A1: Feedstock prices, capacity expansions, and regulatory changes.

Q2: Which regions are the dominant producers of lactic acid?
A2: Asia-Pacific, specifically China and India, account for approximately 75% of global production.

Q3: How does regulatory compliance impact market entry?
A3: It requires high purity levels and extensive documentation, increasing costs but ensuring market access.

Q4: What are the key end-use sectors beyond pharma for lactic acid?
A4: Food, cosmetics, and biodegradable packaging.

Q5: What innovations could influence future market dynamics?
A5: Advancements in bio-fermentation techniques and new purification technologies.

References

[1] MarketsandMarkets. (2022). Pharmaceutical Excipients Market. Retrieved from https://www.marketsandmarkets.com

[2] Grand View Research. (2022). Lactic Acid Market Size, Share & Trends. Retrieved from https://www.grandviewresearch.com